These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26781961)

  • 1. A target-protection mechanism of antibiotic resistance at atomic resolution: insights into FusB-type fusidic acid resistance.
    Tomlinson JH; Thompson GS; Kalverda AP; Zhuravleva A; O'Neill AJ
    Sci Rep; 2016 Jan; 6():19524. PubMed ID: 26781961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusidic acid resistance through changes in the dynamics of the drug target.
    Tomlinson JH; Kalverda AP; Calabrese AN
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25523-25531. PubMed ID: 32999060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and function of FusB: an elongation factor G-binding fusidic acid resistance protein active in ribosomal translocation and recycling.
    Guo X; Peisker K; Bäckbro K; Chen Y; Koripella RK; Mandava CS; Sanyal S; Selmer M
    Open Biol; 2012 Mar; 2(3):120016. PubMed ID: 22645663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenesis mapping of the protein-protein interaction underlying FusB-type fusidic acid resistance.
    Cox G; Edwards TA; O'Neill AJ
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4640-4. PubMed ID: 23836182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribosome clearance by FusB-type proteins mediates resistance to the antibiotic fusidic acid.
    Cox G; Thompson GS; Jenkins HT; Peske F; Savelsbergh A; Rodnina MV; Wintermeyer W; Homans SW; Edwards TA; O'Neill AJ
    Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2102-7. PubMed ID: 22308410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of global patterns and the genetics of fusidic acid resistance.
    Farrell DJ; Castanheira M; Chopra I
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S487-92. PubMed ID: 21546625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates.
    Chen HJ; Hung WC; Tseng SP; Tsai JC; Hsueh PR; Teng LJ
    Antimicrob Agents Chemother; 2010 Dec; 54(12):4985-91. PubMed ID: 20855746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic determinants of resistance to fusidic acid among clinical bacteremia isolates of Staphylococcus aureus.
    Lannergård J; Norström T; Hughes D
    Antimicrob Agents Chemother; 2009 May; 53(5):2059-65. PubMed ID: 19289529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of fusB-mediated resistance to fusidic acid in Staphylococcus aureus.
    O'Neill AJ; Chopra I
    Mol Microbiol; 2006 Jan; 59(2):664-76. PubMed ID: 16390458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of fusidic acid-resistant Staphylococcus aureus isolates in the community of Casablanca (Morocco).
    Elazhari M; Abu-Quatouseh LF; Elhabchi D; Zerouali K; Dersi N; Saile R; Timinouni M; Becker K
    Int J Med Microbiol; 2012 Mar; 302(2):96-100. PubMed ID: 22197537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staphylococcus aureus elongation factor G--structure and analysis of a target for fusidic acid.
    Chen Y; Koripella RK; Sanyal S; Selmer M
    FEBS J; 2010 Sep; 277(18):3789-803. PubMed ID: 20718859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusidic acid resistance, mediated by fusB, in bovine coagulase-negative staphylococci.
    Yazdankhah SP; Asli AW; Sørum H; Oppegaard H; Sunde M
    J Antimicrob Chemother; 2006 Dec; 58(6):1254-6. PubMed ID: 17060340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates.
    O'Neill AJ; Larsen AR; Henriksen AS; Chopra I
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3594-7. PubMed ID: 15328136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008).
    Castanheira M; Watters AA; Mendes RE; Farrell DJ; Jones RN
    J Antimicrob Chemother; 2010 Jul; 65(7):1353-8. PubMed ID: 20430787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of fusidic acid resistance in Staphylococcus aureus.
    Besier S; Ludwig A; Brade V; Wichelhaus TA
    Mol Microbiol; 2003 Jan; 47(2):463-9. PubMed ID: 12519196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic basis of resistance to fusidic acid in staphylococci.
    O'Neill AJ; McLaws F; Kahlmeter G; Henriksen AS; Chopra I
    Antimicrob Agents Chemother; 2007 May; 51(5):1737-40. PubMed ID: 17325218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of fusB-mediated fusidic acid resistance islands in Staphylococcus epidermidis isolates.
    Chen HJ; Tsai JC; Hung WC; Tseng SP; Hsueh PR; Teng LJ
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5842-9. PubMed ID: 21968364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusidic acid resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in a Taiwanese hospital.
    Chen CM; Huang M; Chen HF; Ke SC; Li CR; Wang JH; Wu LT
    BMC Microbiol; 2011 May; 11():98. PubMed ID: 21569422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in rpoB and fusA cause resistance to rifampicin and fusidic acid in methicillin-resistant Staphylococcus aureus strains from a tertiary hospital in Malaysia.
    Lim KT; Teh CS; Yusof MY; Thong KL
    Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):112-8. PubMed ID: 24336696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of elongation factor-G-mediated fusidic acid resistance and fitness compensation in Staphylococcus aureus.
    Koripella RK; Chen Y; Peisker K; Koh CS; Selmer M; Sanyal S
    J Biol Chem; 2012 Aug; 287(36):30257-67. PubMed ID: 22767604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.